Structural basis for a conserved neutralization epitope on the receptor-binding domain of SARS-CoV-2

Huang, K-YA; Chen, X; Mohapatra, A; Nguyen, HTV; Schimanski, L; Tan, TK; Rijal, P; Vester, SK; Hills, RA; Howarth, M; Keeffe, JR; Cohen, AA; Kakutani, LM; Wu, Y-M; Shahed-Al-Mahmud, M; Chou, Y-C; Bjorkman, PJ; Townsend, AR; Ma, C

COVID-19 Collection

Journal article

Structural basis for a conserved neutralization epitope on the receptor-binding domain of SARS-CoV-2

Abstract:: Antibody-mediated immunity plays a key role in protection against SARS-CoV-2. We characterized B-cell-derived anti-SARS-CoV-2 RBD antibody repertoires from vaccinated and infected individuals and elucidate the mechanism of action of broadly neutralizing antibodies and dissect antibodies at the epitope level. The breadth and clonality of anti-RBD B cell response varies among individuals. The majority of neutralizing antibody clones lose or exhibit reduced activities against Beta, Delta, and Omicron variants. Nevertheless, a portion of anti-RBD antibody clones that develops after a primary series or booster dose of COVID-19 vaccination exhibit broad neutralization against emerging Omicron BA.2, BA.4, BA.5, BQ.1.1, XBB.1.5 and XBB.1.16 variants. These broadly neutralizing antibodies share genetic features including a conserved usage of the IGHV3-53 and 3–9 genes and recognize three clustered epitopes of the RBD, including epitopes that partially overlap the classically defined set identified early in the pandemic. The Fab-RBD crystal and Fab-Spike complex structures corroborate the epitope grouping of antibodies and reveal the detailed binding mode of broadly neutralizing antibodies. Structure-guided mutagenesis improves binding and neutralization potency of antibody with Omicron variants via a single amino-substitution. Together, these results provide an immunological basis for partial protection against severe COVID-19 by the ancestral strain-based vaccine and indicate guidance for next generation monoclonal antibody development and vaccine design

Publication status:: Published

Peer review status:: Peer reviewed

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Share
Cite

Cite this record

APA Style

Huang, K.-Y. A., Chen, X., Mohapatra, A., Nguyen, H. T. V., Schimanski, L., Tan, T. K., Rijal, P., Vester, S. K., Hills, R. A., Howarth, M., Keeffe, J. R., Cohen, A. A., Kakutani, L. M., Wu, Y.-M., Shahed-Al-Mahmud, M., Chou, Y.-C., Bjorkman, P. J., Townsend, A. R., & Ma, C. (2023). Structural basis for a conserved neutralization epitope on the receptor-binding domain of SARS-CoV-2. Nature Communications, 14(1), 311–311.

MLA Style

Huang, K-YA, et al. “Structural Basis for a Conserved Neutralization Epitope on the Receptor-Binding Domain of SARS-CoV-2.” Nature Communications, vol. 14, no. 1, 2023, pp. 311–11.

Chicago Style

Huang, K-YA, X Chen, A Mohapatra, et al. 2023. “Structural Basis for a Conserved Neutralization Epitope on the Receptor-Binding Domain of SARS-CoV-2.” Nature Communications 14 (1): 311–11.
Print